Intrinsic Value of S&P & Nasdaq Contact Us

Nuwellis, Inc. NUWE NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Nuwellis, Inc. (NUWE) has a negative trailing P/E of -0.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -977.80%, forward earnings yield 2,500.00%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Forward P/E 0.0 — analysts expect a return to profitability with estimated EPS of $29.82 for FY2028.
  • Trailing Earnings Yield -977.80% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 2,500.00% as earnings recover.

Overall SharesGrow Score: 40/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — NUWE

Valuation Multiples
P/E (TTM)-0.1
Forward P/E0.0
PEG RatioN/A
Forward PEG0.00
P/B Ratio0.68
P/S Ratio0.12
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-10.85
Forward EPS (Est.)$29.82
Book Value / Share$1.63
Revenue / Share$5.12
FCF / Share$-6.75
Yields & Fair Value
Earnings Yield-977.80%
Forward Earnings Yield2,500.00%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -1,813.3 30.60 16,298.44 22,215.95 -
2017 -47.9 3.14 39.46 180.34 -
2018 -7.1 1.56 20.31 24.12 -
2019 -9.2 0.10 83.96 30.32 -
2020 -50.5 0.53 49.04 107.54 -
2021 -16.8 0.33 12.64 41.40 -
2022 -5.4 0.08 6.34 9.17 -
2023 -2.4 0.03 14.93 5.41 -
2024 -5.5 0.06 9.48 7.08 -
2025 -0.7 0.00 4.58 1.45 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-709,842,000.00 $1.29M $-15.79M -1225.1%
2017 $-29,581,300.00 $3.55M $-13.38M -376.6%
2018 $-4,426,660.00 $5M $-17.03M -340.8%
2019 $-976,332.00 $5.51M $-18.11M -328.7%
2020 $-37,341.00 $7.44M $-15.84M -212.8%
2021 $-9,956.73 $7.92M $-19.58M -247.2%
2022 $-2,921.70 $8.54M $-14.53M -170%
2023 $-403.15 $8.86M $-20.21M -228%
2024 $-8.00 $8.74M $-10.62M -121.6%
2025 $-25.39 $8.27M $-17.52M -211.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.69 $-1.69 – $-1.69 $9.01M $9.01M – $9.01M 1
2027 $-0.93 $-0.93 – $-0.93 $10.68M $10.68M – $10.68M 1
2028 $29.82 $29.82 – $29.82 $35.89M $35.89M – $35.89M 1
2029 $59.64 $59.64 – $59.64 $49.45M $49.45M – $49.45M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message